These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3608730)

  • 21. Hydrogen breath test assessment of orocecal transit time: comparison with barium meal study.
    Hirakawa M; Iida M; Kohrogi N; Fujishima M
    Am J Gastroenterol; 1988 Dec; 83(12):1361-3. PubMed ID: 3195540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dose and osmolality of lactulose on the oral-caecal transit time determined by the hydrogen breath test and the reproducibility of the test in normal subjects.
    Diggory RT; Cuschieri A
    Ann Clin Res; 1985; 17(6):331-3. PubMed ID: 4096490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone prevents loperamide inhibition of neurotransmitter induced contractions in rat vas deferens.
    Germany A; Merino A; Contreras E
    Cell Mol Biol; 1983; 29(5):363-6. PubMed ID: 6138154
    [No Abstract]   [Full Text] [Related]  

  • 25. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
    Sykes NP
    Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of opiate receptors in the regulation of colonic transit.
    Kaufman PN; Krevsky B; Malmud LS; Maurer AH; Somers MB; Siegel JA; Fisher RS
    Gastroenterology; 1988 Jun; 94(6):1351-6. PubMed ID: 2834257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome.
    Corbett CL; Thomas S; Read NW; Hobson N; Bergman I; Holdsworth CD
    Gut; 1981 Oct; 22(10):836-40. PubMed ID: 7297914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time.
    La Brooy SJ; Male PJ; Beavis AK; Misiewicz JJ
    Gut; 1983 Oct; 24(10):893-6. PubMed ID: 6618268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reproducibility of orocecal transit time and hydrogen production measured by breath tests].
    Cloarec D; Bruley Des Varannes S; Bizais Y; Lehur PA; Galmiche JP
    Gastroenterol Clin Biol; 1992; 16(5):388-94. PubMed ID: 1526392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loperamide--an opiate receptor agonist with gastrointestinal motility effects.
    Mellstrand T
    Scand J Gastroenterol Suppl; 1987; 130():65-6. PubMed ID: 2820051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of an opiate agonist and antagonist on the human upper gastrointestinal tract.
    Rees WD; Sharpe GR; Christofides ND; Bloom SR; Turnberg LA
    Eur J Clin Invest; 1983 Jun; 13(3):221-5. PubMed ID: 6191994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of loperamide and naloxone on gastric acid secretion in healthy man.
    Caldara R; Cambielli M; Masci E; Guslandi M; Barbieri C; Ferrari C
    Gut; 1981 Sep; 22(9):720-3. PubMed ID: 7297919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
    Shannon HE; Lutz EA
    Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Constipation after tilidine/naloxone and tramadol in comparison to codeine. A dose response study in human volunteers].
    Freye E; Rosenkranz B; Neruda B
    Schmerz; 1996 Oct; 10(5):254-60. PubMed ID: 12799847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of orocaecal transit times assessed by the lactulose/breath hydrogen and the sulphasalazine/sulphapyridine methods.
    Staniforth DH
    Gut; 1989 Jul; 30(7):978-82. PubMed ID: 2569435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loperamide binding to opiate receptor sites of brain and myenteric plexus.
    Mackerer CR; Clay GA; Dajani EZ
    J Pharmacol Exp Ther; 1976 Oct; 199(1):131-40. PubMed ID: 10422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limitations of indirect methods of estimating small bowel transit in man.
    Pressman JH; Hofmann AF; Witztum KF; Gertler SL; Steinbach JH; Stokes K; Kelts DG; Stone DM; Jones BR; Dharmsathaphorn K
    Dig Dis Sci; 1987 Jul; 32(7):689-99. PubMed ID: 3109861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The analgesic tramadol has minimal effect on gastrointestinal motor function.
    Wilder-Smith CH; Bettiga A
    Br J Clin Pharmacol; 1997 Jan; 43(1):71-5. PubMed ID: 9056055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.